International Journal of Vascular Medicine, 2022 Background. Many of the therapeutic proposals for COVID-19 have been associated with adverse effects, including the risk of QT interval prolongation and torsades de pointes (TdP). The objective was to determine the use of drugs with a risk of QT interval
Andrés Gaviria-Mendoza +4 more
doaj +2 more sources
Trends in Opioid Use in a Cohort of Patients with Rheumatoid Arthritis
Pain Research and Management, 2020 The objective was to determine the trend in the use of opioid analgesics in a cohort of patients diagnosed with and treated for rheumatoid arthritis (RA) in 24 cities in Colombia. This retrospective cohort study included adult patients diagnosed with RA,
Manuel E. Machado-Duque +3 more
doaj +2 more sources
Evaluation of Treatment Patterns and Direct Costs Associated with the Management of Neuropathic Pain
Pain Research and Management, 2020 Background. Neuropathic pain has a prevalence of 2–17% in the general population. Diagnosis and treatment of neuropathic pain are not fully described in different populations.
Manuel E Machado-Duque +3 more
doaj +2 more sources
Persistence of Weekly Injectable Semaglutide Use in Patients with Diabetes Mellitus and Obesity: A Retrospective Follow-Up in Colombia [PDF]
Drugs - Real World OutcomesBackground Semaglutide is an effective antidiabetic agent that is injected weekly to induce weight reduction, and the impact on cardiovascular outcomes is favorable.
Manuel Enrique Machado-Duque +3 more
doaj +2 more sources
Conocimientos, actitudes y prácticas de farmacovigilancia en el contexto de la COVID-19 en profesionales de la salud del Seguro Social del Perú [PDF]
Revista Peruana de Medicina Experimental y Salud Pública, 2022 El estudio tuvo como objetivo evaluar el conocimiento, las actitudes y prácticas de un grupo de profesionales de la salud sobre la farmacovigilancia en el contexto de la COVID-19 en el Seguro Social de Salud del Perú (EsSalud).
L. Yesenia Rodríguez-Tanta +8 more
doaj +2 more sources
Prescription patterns of ambrisentan in some cities of Colombia
The Clinical Respiratory JournalIntroduction Ambrisentan is a selective type A endothelin receptor antagonist that has shown significant effectiveness and safety in the management of patients with pulmonary hypertension.
Luis Fernando Valladales‐Restrepo +4 more
doaj +2 more sources
Pain Research and Management, 2020 The objective of this cohort study was to determine the association between the use of tramadol in emergency departments and the later consumption of opioids at the outpatient level in a group of patients from Colombia. Based on a medication dispensation
Jorge Enrique Machado-Alba +4 more
doaj +2 more sources
2.7 Farmacovigilancia durante la pandemia de COVID-19
Anales del Sistema Sanitario de Navarra, 2023 Durante la pandemia de COVID-19, un papel fundamental de la Farmacovigilancia y del Centro de Farmacovigilancia de Navarra ha sido disponer de forma temprana de información de seguridad actualizada sobre los tratamientos para la infección por SARS-CoV-2
Gabriela Elizondo Rivas +3 more
doaj +2 more sources
Use of resources and cost in the management of gastrointestinal hemorrhage caused by oral anticoagulants: a retrospective cohort analysis [PDF]
Cost Effectiveness and Resource AllocationBackground Oral anticoagulants (OACs) used to treat nonvalvular atrial fibrillation (NVAF) are frequently associated with complications, especially gastrointestinal hemorrhage (GH).
Manuel Enrique Machado-Duque +8 more
doaj +2 more sources
Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia
The Clinical Respiratory JournalIntroduction Pulmonary hypertension (PH) is a chronic disease characterized by a progressive rise in pulmonary artery blood pressure. The objective was to describe the treatment patterns among ambulatory patients with pulmonary arterial hypertension (PAH)
Manuel Machado‐Duque +8 more
doaj +2 more sources